|
|
|
|
How Patent Vulnerability Impacts Valuation
en tell business leaders who attend my course on Valuing Early-Stage Technologies, valuing patents isnt rocket science.It is much more difficult. Or to paraphrase Winston Churchill, valuing patents is a riddle, wrapped in a mystery, inside an...
|
|
|
Cushioning pharma's fall from the patent precipice
Pharmaceutical Technology Europe Volume 22, Issue 2 123 If there was ever a question about the importance of intellectual property (IP) and patent protection in the pharmaceutical industry, it is about to be answered as the world's top drug makers...
|
|
|
PriceDoc.com Receives U.S. Patent for Online Healthcare Bidding
Companies mentioned in this article: PriceDoc.com SOLANA BEACH, Calif., Feb.9 /PRNewswire/ -- PriceDoc.com, a free, transparent healthcare pricing service and Web site, announced today that the U.S. Patent and Trademark Office issued PriceDoc ...
|
|
|
PriceDoc.com's online healthcare service acquisition and negotiation system awarded U.S. patent
PriceDoc.com, a free, transparent healthcare pricing service and Web site, announced today that the U.S.Patent and Trademark Office issued PriceDoc patent #7,657,479 for its online system of healthcare service acquisition and negotiation, making...
|
|
|
NexBio Granted United States Patent Covering DAS181 (Fludase(R) *) and its Use for Prevention and Treatment of
SAN DIEGO, Calif., Feb.8 /PRNewswire/ NexBio, Inc. today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled 'Class of Therapeutic Protein Based Molecules'. This patent...
|
|
|
Alnylam Pharmaceuticals receives 'Notice of Allowance' from USPTO
Alnylam Pharmaceuticals, Inc.(Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the Soutschek and Manoharan patent (Application No....
|
|
|
UK court rules HGS gene patent invalid -lawyers
* Ruling upholds earlier decision that HGS patent is invalid * Case shows speculation on future use not enough for patent * Experts say UK ruling could influence other jurisdictions LONDON, Feb 9 (Reuters) - A British court has upheld a ruling...
|
|
|
UK court rules HGS gene patent invalid -lawyers
* Ruling upholds earlier decision that HGS patent is invalid * Case shows speculation on future use not enough for patent * Experts say UK ruling could influence other jurisdictions LONDON, Feb 9 (Reuters) - A British court has upheld a ruling...
|
|
|
Cynosure settles patent infringement lawsuit against CoolTouch
Cynosure, Inc.(Nasdaq: CYNO), developer of the award-winning Smartlipo LaserBodySculpting(SM) procedure for minimally invasive removal of fat, and its largest shareholder, El.En. S.p.A, today announced a settlement of their patent infringement...
|
|
|
USPTO awards NexBio patent covering sialidase pharmaceutical compositions and methods of treating influenza
NexBio, Inc.today announced the issuance by the United States Patent and Trademark Office of United States Patent No. 7,645,448 entitled "Class of Therapeutic Protein Based Molecules". This patent covers NexBio's sialidase...
|
|
|
HC rejects Bayer's patent plea on cancer drug
A bench of the High Court here today dismissed an appeal by Bayer, the German pharmaceutical company, on an earlier decision to allow marketing of generic versions of its patented drug.The earlier decision came last year by a single judge of the same...
|
|
|
UK court rules HGS gene patent invalid -lawyers
LONDON, Feb 9 (Reuters) - A British court has upheld a ruling invalidating a patent on a gene sequence held by Human Genome Sciences, handing victory in the case to Eli Lilly which had challenged HGS's patent, lawyers familiar with the case said on...
|
|
|
UK court rules HGS gene patent invalid -lawyers
LONDON, Feb 9 (Reuters) - A British court has upheld a ruling invalidating a patent on a gene sequence held by Human Genome Sciences, handing victory in the case to Eli Lilly which had challenged HGS's patent, lawyers familiar with the case said on...
|
|
|
Approach patents body first: HC to pharma firms
Delhi High Court dismisses six petitions of drug majors.The Delhi High Court has put an end to the trend among pharmaceutical companies to take patent litigation directly to court without first approaching the Intellectual Property Appellate Board ...
|
|
|
GE Healthcare Sues Beckman Coulter Genomics for Infringing Nucleic Acid Purification Patents
GE Healthcare UK has filed suit against Beckman Coulter Genomics, alleging that the firm is infringing two patents that cover technologies for isolating and purifying nucleic acids.The complaint, filed Dec. 18 in the US District Court for the...
|
|
|
Silence Therapeutics obtains notice of allowance for cancer drug
Silence Therapeutics has reported that the US Patent and Trademark Office has issued the company a notice of allowance on a patent application directed to methods of treatment using a high-value therapeutic target in the area of oncology.Known as...
|
|
|
BIO Joins Stakeholders In Expressing Concerns With Efforts To Restrict Gene Patenting
The Biotechnology Industry Organization (BIO) released a letter to Health and Human Services Secretary Kathleen Sebelius regarding the potentially harmful recommendations of the Secretary's Advisory Committee on Genetics, Health and Society (SACGHS) in its...
|
|
|
Idera Sues USPTO To Extend Cancer Treatment Patents
Citing the recent decision in Wyeth v.Kappos, Idera Pharmaceuticals Inc. has sued the U.S. Patent and Trademark Office, claiming the patent authority miscalculated an extension for two of its patents covering a cancer treatment by a...
|
|
|
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Cov
Alnylam Pharmaceuticals, Inc.(Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the Soutschek and Manoharan patent (Application No....
|
|
|
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics
CAMBRIDGE, Mass.-- (BUSINESS WIRE) -- Alnylam Pharmaceuticals, Inc.(Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the Soutschek and...
|
|
|
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Cov
Alnylam Pharmaceuticals, Inc.(Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office (USPTO) has awarded a Notice of Allowance for the Soutschek and Manoharan patent (Application No....
|
|
|
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics
Companies mentioned in this article: Alnylam Pharmaceuticals, Inc.CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that the United States Patent and Trademark...
|
|
|
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Cov
New Soutschek and Manoharan Patent Covers Chemically Modified Small Interfering RNAs (siRNAs) with Drug-Like Properties for In Vivo Delivery CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 8, 2010 - Alnylam Pharmaceuticals, Inc.(Nasdaq: ALNY), a leading RNAi...
|
|
|
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Covering RNAi Therapeutics
New Soutschek and Manoharan Patent Covers Chemically Modified Small Interfering RNAs (siRNAs) with Drug-Like Properties for In Vivo Delivery CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc.(Nasdaq: ALNY - News), a leading RNAi...
|
|
|
Alnylam Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Broadly Cov
New Soutschek and Manoharan?Patent Covers Chemically Modified Small Interfering RNAs (siRNAs) with Drug-Like Properties for In Vivo Delivery CAMBRIDGE, Mass.(BUSINESS WIRE) Alnylam Pharmaceuticals, Inc? (Nasdaq: ALNY), a leading RNAi therapeutics...
|
